Skip to content

Study on Urinary Metabolomics of Premenstrual Dysphoric Disorder Patients with Liver-Qi Depression Syndrome Treated With Xiaoyao Powder

Study on Urinary Metabolomics of Premenstrual Dysphoric Disorder Patients with Liver-Qi Depression Syndrome Treated With Xiaoyao Powder

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR1900002634
Enrollment
Unknown
Registered
2019-09-29
Start date
2019-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual Dysphoric Disorder

Interventions

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. It conforms to the diagnostic criteria of PMDD in the 5th edition of the Manual of Diagnosis and Statistics of Mental Diseases (DSM-5), and the diagnosis of TCM syndromes conforms to the syndrome of Liver-qi depression. 2. Women aged between 18 and 30 are of unlimited ethnic origin. 3. The basic regularity of menstrual cycle (fluctuation range < 3d) is 21-35 days. 4. Clear-minded and independent judgement; able to understand the purpose of this study and cooperate voluntarily. 5. No major diseases, no heart, liver and kidney tumors, brain tumors or other brain diseases, no history of taking psychotropic drugs.

Exclusion criteria

Exclusion criteria: 1. Drugs for PMDD were used within three months. 2. History of drug abuse. 3. Those who participated in other drug clinical trials within one month before screening. 4. Diseases of the blood system. 5. Pregnant or lactating women. 6. Chronic history of five visceral diseases such as heart and spleen. 7. Ovariectomy or abortion within six months, contraceptive use.

Design outcomes

Primary

MeasureTime frame
Urine metabonomics;

Countries

China

Contacts

Public ContactXu Mengbai

Beijing University of Chinese Medicine

kimy127@163.com+86 18765959418

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026